Lymphopenia is a highly significant risk factor for progression to lower tract disease during the first 3 months after HCT ( Ljungman et al , 2001 ; Chemaly et al , 2006 ).
← all excerpts
The challenge of respiratory virus infections in hematopoietic cell transplant recipients.
1
—
—